First results announced from study on antibodies against SARS-CoV-2 on Cyprus population

Preliminary data from an ongoing study in Cyprus show that antibody levels following vaccination with the first and second dose against COVID-19 are at much higher levels than on people who were infected with the disease, as well as that the levels drop a few months after the second vaccine dose, the University of Cyprus Biobank announced on Monday.

These data have not been included in the publication of the study but are in line with relevant observations made by other scientists studying different populations and enhance the view that a decision for a third booster vaccine dose was appropriate, the press release said. Studies by scientists in different countries, it added, have shown that although there is no absolute correlation, it has been observed that antibody levels reflect to a certain degree the adequacy of immunity of the organism.

Source: Cyprus News Agency